chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case reported by a physician, describes the occurrence of increased appetite (strong appetite the next day after second Moderna shot) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced increased appetite (strong appetite the next day after second Moderna shot). At the time of the report, increased appetite (strong appetite the next day after second Moderna shot) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information.
HPV #3 at 09:00 hrs, by 18:00 hrs in ER with 102 degree F fever, visual changes, numbness in hands and feet. Kept in ER overnight - no cause found.
mom heard gurgling sounds p/pt was in bed a few hrs-found pt stiff w/eyes rolled back in head, unresponsive w/alot of saliva; post ictal period
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot number FD0809. The local Public Health District, per guidance from the local Department of Health (DH), Centers for Disease Control and Prevention (CDC), and Pfizer have determined that the dose of vaccine that you received is valid.
Migraine; Bad case of vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Bad case of vertigo) and MIGRAINE (Migraine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Bad case of vertigo) and MIGRAINE (Migraine). At the time of the report, VERTIGO (Bad case of vertigo) was resolving and MIGRAINE (Migraine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-105529 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: medical history was updated On 05-May-2021: outcome of the event was updated. On 09-May-2021: outcome of the event was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-105529:first dose case
Onset of extreme lightheadedness, brain fog, and extreme fatigue. Heart palpitations randomly especially when standing and walking. Extreme shortness of breath, inability to walk up a single flight of stairs. These symptoms gradually ramped up over the course of a week or so. Eventually developed anemia which was detected during a doctor's visit when dissolved oxygen was below 90 for a prolonged duration.
This spontaneous report was received from a physician referring to a 6-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 12-AUG-2017, the patient was vaccinated with improperly stored ROTATEQ orally, lot # M041184 with expiration date on 31-MAY-2018 for prophylaxis (dose was not provided). The vaccine was exposed to a temperature of 49 Fahrenheit degrees for 16 hours on 20-MAY-2017, 17-JUN-2017 and 21-JUN-2017. The vaccine was exposed to a temperature of 48 Fahrenheit degrees for 16 hours on 27-MAY-2017, 02-JUN-2017 and 03-JUN-2017. The vaccine was exposed to a temperature of 47 Fahrenheit degrees for 16 hours on 09-JUN-2017, 13-JUN-2017, 22-JUN-2017, 23-JUN-2017, 28-JUN-2017 and 29-JUN-2017 and for 70 hours on 30-MAY-2017. The vaccine was exposed to a temperature of 35 Fahrenheit degrees for 16 hours on 27-JUN-2017, 20-JUL-2017 and 28-JUL-2017 and for 46 hours on 17-JUL-2017 and 26-JUN-2017. The vaccine was exposed to a temperature of 34 Fahrenheit degrees for 16 hours since 29-JUN-2017 until 01-JUL-2017, on 03-JUL-2017, 06-JUL-2017, 07-JUL-2017, 19-JUL-2017 and 26-JUL-2017, for 40 hours on 05-JUL-2017 and for 46 hours on 10-JUL-2017. The vaccine was exposed to a temperature of 33 Fahrenheit degrees for 16 hours on 08-JUL-2017 and since 11-JUL-2017 until 15-JUL-2017 and on 27-JUL-2017. The vaccine was also exposed to a temperature of 32 Fahrenheit degrees for 16 hours on 22-JUL-2017 and 01-AUG-2017. Additionally, it was reported that digital data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-1709USA012770: US-009507513-1709USA007325: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA012764: US-009507513-1709USA012766: US-009507513-1711USA003163: US-009507513-1711USA003164: US-009507513-1711USA003162: US-009507513-1709USA012767: US-009507513-1711USA003160: US-009507513-1711USA003159: US-009507513-1711USA003157: US-009507513-1711USA003165: US-009507513-1711USA003158:
On 4/1/08 upon entering the vaccines into child profile, I noticed that the lot number did not match the varicella in stock. I did more research and found the lot number to match that of the adult Zostavax. Pt was to receive varicella number 2 but was mistakenly given Zostavax. The provider contacted the mother and child was doing fine however we did recommend the patient go to er if needed and follow up to discuss mistake.  Pt at that time was not having any reaction.
Within 4 hours of vaccine,  I had fatigue. By the next morning, I developed fever. Sublingual temp up to 100.8 but also had chills. I had fever, fatigue, chills, and myalgia that peaked at 33 hours post vaccination. I took multiple doses of 600mg - 800 mg ibuprofen. By 41 hours post vaccination, symptoms had resolved completely.  Dose 1 Dec 23, 2020, Lot EH 9899 Laryngitis like illness (cough, phlegm at larynx, hoarse voice)  December 29,30, 2020 resolved. + Covid PCR on Jan1, 2021 (frontal headache, fatigue, fever) Delayed dose two until January 27, 2020 I am a pediatrician and I work in an Urgent Care with Covid positive patients. This report is for your tracking purposes.  I would have considered seeing a PCP if I were not a physician.
Patient started feeling dizzy, nauseous and increased heart rate. Patients symptoms got a little better before leaving with her husband.
Initial unsolicited report received from a nurse on 08 September 2015. This case involves a 66-year-old male patient who was vaccinated with an intramuscularly dose (dose and dose series not reported) of FLUZONE HD (batch number UI428AA, expiry date 18 March 2016), in the left deltoid on 03 September 2015. Illness at time of vaccination was reported as not applicable. Pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as hypertension (HTN), arthritis, and remote history of prostate cancer (CA). Concomitant medications were not reported. On 03 September 2015, same day following the vaccination, the patient visited the ENT specialist for acute hearing loss. It was not indicated if the hearing loss was unilateral or bilateral, or how soon after the vaccination it was noted, but was stated as soon after the vaccination. It was reported that, patient required emergency room/doctor visit. Lab data included and corrective treatment was not reported. At the time of this report, the patient had not recovered from the event. Upon medical review, the case was considered as serious due to important medical event: acute hearing loss. List of documents held by sender: none.
The same night as getting 2nd Moderna vaccine, I had a 101 F degree fever and chills. Only after taking Tylenol did the temperature decrease to 99.3.
developed a UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (developed a UTI) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included no adverse event.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced URINARY TRACT INFECTION (developed a UTI). At the time of the report, URINARY TRACT INFECTION (developed a UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  Although a temporal association exist, there is still limited information regarding the reported event at this time. Patient's medical history, list of concomitant medications, clinical details any laboratory test for UTI are lacking.  Urinary tract infection is of an infective etiology and the risk increases with advanced age above 65 years hence assessed as unlikely related to product use.; Reporter's Comments: Although a temporal association exist, there is still limited information regarding the reported event at this time. Patient's medical history, list of concomitant medications, clinical details any laboratory test for UTI are lacking.  Urinary tract infection is of an infective etiology and the risk increases with advanced age above 65 years hence assessed as unlikely related to product use.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 67 years old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unknown date in 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for prophylaxis. As a result of zoster vaccine live (ZOSTAVAX), in 2014, the patient was caused to suffer shingles, including any and all of its sequelae. As a result of her receipt of zoster vaccine live (ZOSTAVAX), the patient had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. The outcome of the event shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Flu like symptoms, joints and body, slight fever. 24 hours - took over Ibuprofen for two days.
Client states about 14 hours after his vaccine he had violent chills and shaking that lasted for about 3 hours with severe pain at the injection site.
Sore arm; Sick; Really big bump on her arm; Twitch in her right eye; Soreness and lump under skin at shot point; Soreness and lump under skin at shot point; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 57-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 08Aug2021 15:15 (at the age of 57 years) (Batch/Lot Number: PAA165969) as DOSE 2, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included diabetes from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had known allergy to drug Codeine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left Right on 18Jul2021 03:00 PM (Batch/Lot Number: EW0178) as DOSE 1, SINGLE for covid-19 immunisation and experienced sore arm. Patient was a 57-year-old consumer who stated that she filled out a safety report about adverse effects she had but was wondering if Pfizer could tell her how long they might last. She stated that she got really sick for three days after the shot and about an hour after getting the shot she had a really big bump on her arm. She stated that the bump was there for 2.5 weeks. She stated that during those times she developed a twitch in her right eye and was still having the twitch. She stated that her arm was really sore and that you couldn't touch it, it was so sore. She stated that the only had the soreness and the bump for 2.5 weeks after the second dose. She stated that after the first shot she had a sore arm but there was no bump like there was after the second shot, she had the shots in two different arms. The 1st shot was in the left arm and the 2nd shot was in her right arm and it was really painful. She stated that after the second shot she developed a twitch in her right eye and wanted to know if anyone else had reported it and how long it last for? After 2nd shot got very ill for 3 days. Continued to had soreness and lump under skin at shot point and had developed a consistent twitch in right eye, did not have more than sore arm after first shot. She had an elderly mother that lives with her and she did not really want to go to a doctor's office and be exposed to anything. The treatment received for the adverse events was unknown. The clinical outcome of the events soreness and lump under skin at shot point, Soreness and lump under skin at shot point was not recovered and remaining all other events was unknown at the time of report.  Follow-up attempts are completed. No further information is expected.
Dry mouth, tingling of tongue, generalized weakness. Pt was treated with Benadryl @ the ER. Extensive bloodwork and urine testing done all of which returned normal.
Tightness in throat; Coughing; Dizziness; Legs tingling; This is a spontaneous report from a contactable consumer (patient). This non-pregnant 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 10:45 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy and hypertension, both from unknown dates and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included losartan potassium 100 mg, and diltiazem hydrochloride 240 mg, both from unknown dates for unknown indications. The patient previously received sodium benzoate from an unknown date for an unknown indication and experienced drug allergy, hydrochlorothiazide from an unknown date for an unknown indication and experienced drug allergy, unspecified angiotensin converting enzyme (ACE) inhibitors from unknown dates for unknown indications and experienced drug allergy; cefazolin from an unknown date for an unknown indication and experienced drug allergy; and hydrocodone-acetaminophen from an unknown date for an unknown indication and experienced drug allergy. On 03Mar2021 at 10:45, the patient experienced tightness in throat, coughing, dizziness, and leg tingling. The events required a physician office visit and emergency department visit. The patient was treated with intravenous diphenhydramine hydrochloride (BENADRYL) and steroids. The clinical outcomes of tightness in throat, coughing, dizziness, and leg tingling were recovered on unspecified dates in 2021. It was also reported that since vaccination the patient had not been tested for COVID-19.
Mother reports 2.3 red lesion appeared 2 days post vaccine at injection site. Erythema at injection site.
Pt was supposed to receive Pfizer BIVALENT vaccines but I administered the Pfizer primary instead. Pt had no symptoms after vaccine was administered but mom called on 3/31/23 stating pt has been having nausea and vomiting and fatigue
Based on phone call from daughter (who had the same symptoms), about 8 hours after the immunization at around 12 AM he began to have swelling of the face and neck, sensation of throat closing, and some trouble breathing. They went to the emergency room and he was treated, watched, and then sent home.
Pt was in observation after receiving 1st dose Covid vaccine when throat began to swell and she started having difficulty swallowing. VSS: SpO2 98%, HR 82, 118/78, RR 20, T 98,6 temporal.  50mg of diphenhydramine administered PO @ 1531. EMS called and arrived to check pt. Pt refused transfer to hospital.
Had shot sub q (R) upper arm on 3/20/2012 took Band Aid off Wednesday AM - noting later that night had 5-6 papules non pruritic - no systemic reactions & this AM 3/22 4x4 induration red and warm. Still without systemic reaction -> rec. warm compress, BENADRYL 40mg 1 4q hr - 24.
Breakthrough case admission after 4 vaccines Moderna 1/23/21 Lot# 026L20A;  Moderna 2/23/21 Lot# 031L20A; Moderna 11/26/21 Lot# 039F21A;  Moderna 7/28/22 Lot# 016B22A
3 1/4 x 4 3/4 inch area of redness, induration & heat on right thigh with small surrounding area of pinkness, non tender to touch.
extremely itchy rash on arms, neck, chest, eyes and head - still experiencing itchy rash on neck and chest - 17 days after vaccine
Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: numbness, tingling, itching in face immediately after injection, relieved several hours after administration of benadryl
CONGESTED FEELING IN CHEST; HEART RACING; CONGESTED FEELING IN THROAT; TEMPORAL/FRONTAL LOBE HEADACHE; FEVERISH/LOW GRADE FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure no follow up will be requested for this case. No concomitant medications were reported.  On 12-APR-2021, the subject experienced congested feeling in chest. On 12-APR-2021, the subject experienced heart racing. On 12-APR-2021, the subject experienced congested feeling in throat. On 12-APR-2021, the subject experienced temporal/frontal lobe headache. On 12-APR-2021, the subject experienced feverish/low grade fever. Laboratory data included: Body temperature (NR: not provided) 100.2 F, and Heart rate (NR: not provided) 120 {beats}/min. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from temporal/frontal lobe headache, feverish/low grade fever, heart racing, congested feeling in chest, and congested feeling in throat. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case assessed as non-serious
Monday night-headache, chill, fever 38.4F, sinusitis,body pain Tuesday-headache,chill,sinusitis,earache,neck pain,body pain Wednesday-chill,sinusitis, body pain,earache,neck pain Thursday-chill,sinusitis resulting to loss of smell.and taste,body pain esp. upper back, vertigo with dizziness,earache,neck.pain Friday-sinusitis(loss of smell and taste), a bit chill, a bit of body pain, a bit of vertigo
Initial unsolicited misuse report received from non-healthcare professional (medical assistant) on 01 September 2016. This case is linked to case number -2016SA162934. (Same vaccine, same lot number, same reporter). This case involves female patient (age not reported) who was vaccinated with dose of Adacel (batch number: U5467AC, expiry date: 08 October 2018 and site of administration was not reported) and injection of Tubersol (batch number C4652AA, expiry date: 22 January 2017 and site of administration was not reported) both by Intradermal route on an unspecified date. The patient's Illness at time of vaccination includes none as per reporter, pre-existing physician diagnosed allergies, birth defects, medical conditions (specify): not reported and concomitant medications were not reported. On an unspecified date, patient received 0.1 milliliter of Adacel instead of Tubersol and following vaccination patient experienced redness and itching at injection site and hard bubble and bruising at the site of the administration of the Tubersol. It was a case of wrong vaccine administered. Laboratory data and corrective treatment was not reported. Outcome of events reported as unknown. List of documents held by sender: none.
Vaccine not administered via SC route.; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not provided.    On 21-APR-2022, the patient was vaccinated with 1 dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX), both intramuscular in the deltoid area (incorrect route of product administration) for prophylaxis (strength, exact dose, frequency, lot number and expiration date for two vaccines were not reported).   This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2204USA007790:
Administered Tdap instead of DTaP. Administration site right deltoid. Several attempts to re-contact family to administer DTaP and to get weight. No response from family.
On 1/5/15 mother called in that pt had fever with redness and swelling and pain at injections site.  Seen that same day and antibiotics started for cellulitis.  Rechecked 1/12/15 and s/s have resolved.
Twinges in different parts of my body, tingling and pain from my toes to my buttocks, trouble sleeping, tingling in hands, especially the right one, weakness in legs like they would give out, pain 9/10, shooting pain in my legs, pain in my feet, felt poorly